Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2007
11/29/2007CA2651487A1 Methods for treating chemotherapy and radiation therapy side effects
11/29/2007CA2649810A1 Cladribine regimen for treating multiple sclerosis
11/29/2007CA2649722A1 Use of an antibody
11/28/2007EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists
11/28/2007EP1858535A2 Compositions comprising actinidia and methods of use thereof
11/28/2007EP1545620B1 Pharmaceutical compositions comprising cyclosporin for oral administration
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1383912A4 Pd-1, a receptor for b7-4, and uses therefor
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1326638B1 Vaccines against cancers
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007CN101077884A Modification method for protein or polypeptide antigen, and application thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077386A Traditional Chinese medicine composition for treating allergic purpura
11/28/2007CN101077210A Whole jujube liquid with multiple health care functions
11/28/2007CN101077190A Process for producing silkworm cocoon foodstuff nutriment
11/28/2007CN101077183A Novel capilary artemisia red date composite health care beverage and its processing technology
11/28/2007CN101077108A Health-care tea and its preparing process
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350908C Novel anti-allergic anti-inflammatory composite
11/27/2007US7301068 Nonhuman model animal of Th2-mediated hyperimmune response
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300942 For therapy of a fungal infection
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007CA2294165C Frozen dessert
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007132900A1 Skin moisturizer and therapeutic agent for dermatitis
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132790A1 Liposome having lipid membrane containing bacterial cell component
11/22/2007WO2007132546A1 Pharmaceutical containing thiazole derivative as active ingredient
11/22/2007WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007WO2007132179A2 Therapeutics comprising pyridinium derivatives
11/22/2007WO2007112750A3 Tablets and capsules comprising immunogens for oral administration
11/22/2007WO2007109330A3 S1p receptor modulating compounds
11/22/2007WO2007071777A3 Immuno-rna-constructs
11/22/2007WO2006057886A8 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES
11/22/2007US20070270499 Use for 2-amino-2-propane-1, 3-diols
11/22/2007US20070270496 Pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
11/22/2007US20070270478 e.g. 3-[4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2,3-difluoro-phenyl)-acrylonitrile; immunosuppressant; bioavailability; side effect reduction; interleukin-2 inhibitor
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270441 Combination
11/22/2007US20070270429 Function Inhibitor of Effector Cell
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070269443 Therapeutic Regimens for Baff Antagonists
11/22/2007US20070269441 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
11/22/2007US20070269428 Method for the Treatment of Multiple Sclerosis by Inhibiting Il-17 Activity
11/22/2007US20070269415 Lotus extract and lactic acid bacterium active ingredients exhibit synergistic amelioration or treatment of allergic diseases including hay fever, bronchial asthma and dermatitis, such as atopic dermatitis; foods; reduced immunoglobulins (IgE);interleukin-4 inhibitor; tumor necrosis factor inhibitors
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269376 Method for Determining Dosage for an Oral Killed Vaccine
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007US20070269372 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes
11/22/2007US20070269371 Antibodies with altered effector functions
11/22/2007CA2652475A1 Liposome having lipid membrane containing bacterial cell component
11/22/2007CA2651765A1 A medicament containing a thiazole derivative as an active ingredient
11/22/2007CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857121A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1856153A1 Ykl-40 monoclonal antibodies
11/21/2007EP1856147A1 A molecule and chimeric molecules thereof
11/21/2007EP1856135A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
11/21/2007EP1856116A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
11/21/2007EP1856062A1 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine mediated diseases
11/21/2007EP1856045A1 1-acetic acid-indole derivatives with pgd2 antagonist activity
11/21/2007EP1855720A1 Use of a modified proxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
11/21/2007EP1855692A1 Composition for reducing the exudation of serum proteins
11/21/2007EP1855682A2 Aminopterin dosage forms and methods for inflammatory disorders
11/21/2007EP1855550A2 Nutritional composition with probiotics
11/21/2007EP1525223B1 Ox40 (=cd134) receptor agonists and therapeutic use
11/21/2007EP1431284B1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/21/2007EP1414492B1 Method for treating multiple myeloma
1 ... 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 ... 1172